How have VIV shares performed in 2024?

Avivagen's stock was trading at C$0.01 at the beginning of the year. Since then, VIV stock has increased by 0.0% and is now trading at C$0.01. View the best growth stocks for 2024 here .

When is Avivagen's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, April 25th 2024. View our VIV earnings forecast .

What other stocks do shareholders of Avivagen own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Avivagen investors own include Astrotech (ASTC) , Arcturus Therapeutics (ARCT) , Aptose Biosciences (APTO) , Appili Therapeutics (APLIF) , Argan (AGX) , Applied Genetic Technologies (AGTC) , AES (AES) and AbbVie (ABBV) .

How do I buy shares of Avivagen?

Shares of VIV stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor , Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. Compare Top Brokerages Here .

CVE:VIV

Avivagen (VIV) Stock Price, News & Analysis

→ Did You Get Your Free Bitcoin Yet? (From Crypto Swap Profits) (Ad)

Free VIV Stock Alerts

C$0.0050

0.00 (0.00%)

(As of 03/5/2024)

Compare

Today's Range: C$0.01
▼
C$0.01
50-Day Range: C$0.01
▼
C$0.01
52-Week Range: C$0.01
▼
C$0.08

Volume: 2,820 shs
Average Volume: 49,827 shs
Market Capitalization: C$388,450.00

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Earnings Headlines

Get Avivagen alerts:

Ad Behind the Markets

Tiny Biotech Stock Wins $75 Billion Patent

A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.

Find out more here >>>

About Avivagen Stock (CVE:VIV)

Avivagen Inc. focuses on developing and commercializing products for livestock feeds that support immune function and help animals to achieve their growth and productivity. The company offers OxC-beta Livestock, a premix for inclusion in livestock feeds; Vivamune health chews for dogs; Dr. Tobias dog chews; and Dr. Tobias Beta blend for the human immune system. It serves in Canada, Mexico, Brazil, the Philippines, Taiwan, and Thailand. Avivagen Inc. was incorporated in 2005 and is headquartered in Ottawa, Canada.

VIV Stock Price History

30 days | 90 days | 365 days | Advanced Chart

VIV Stock News Headlines

March 6, 2024 | investing.com

Avivagen Inc (VIV)

March 6, 2024 | finance.yahoo.com

Canadian Investment Regulatory Organization Trading Halt - VIV

April 19, 2024 | Paradigm Press (Ad)

Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS

You might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.

February 20, 2024 | theglobeandmail.com

Avivagen: Top 10 Undervalued Healthcare Sector Stocks on TSX-V (VIV)

January 3, 2024 | finance.yahoo.com

Pure Harvest Corporate Group, Inc. (PHCG)

November 5, 2023 | theglobeandmail.com

Closing Bell: Avivagen Inc flat on Monday (VIV)

October 17, 2023 | finance.yahoo.com

Avivagen Announces New 500Kg Order for OxC-beta™

August 25, 2023 | theglobeandmail.com

Closing Bell: Avivagen Inc flat on Friday (VIV)

April 19, 2024 | Paradigm Press (Ad)

Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS

July 31, 2023 | technews.tmcnet.com

Avivagen Provides Corporate Updates

July 29, 2023 | theglobeandmail.com

Closing Bell: Avivagen Inc up on Friday (VIV)

July 24, 2023 | finance.yahoo.com

Avivagen Announces New Orders for 1.1 Tonnes of Oxc-Beta™ Livestock Product

July 19, 2023 | theglobeandmail.com

Closing Bell: Avivagen Inc flat on Tuesday (VIV)

July 15, 2023 | theglobeandmail.com

Avivagen: Top 10 Undervalued Growth Stocks on TSX-V (VIV)

June 27, 2023 | theglobeandmail.com

Closing Bell: Avivagen Inc down on Monday (VIV)

May 25, 2023 | msn.com

An existing Avivagen customer increases order size

May 25, 2023 | finance.yahoo.com

Avivagen Announces Significant Increase in Sales to an Existing Customer

May 23, 2023 | sg.finance.yahoo.com

Avivagen Inc. (VIV.V)

May 18, 2023 | tmcnet.com

Avivagen Announces Review of Strategic Alternatives

April 27, 2023 | theglobeandmail.com

Closing Bell: Avivagen Inc down on Thursday (VIV)

April 19, 2023 | finance.yahoo.com

Avivagen Announces AGM Results

April 7, 2023 | theglobeandmail.com

Closing Bell: Avivagen Inc flat on Thursday (VIV)

April 6, 2023 | theglobeandmail.com

Closing Bell: Avivagen Inc flat on Wednesday (VIV)

March 28, 2023 | finance.yahoo.com

Avivagen Inc. Provides Update on Securities for Service Agreements With CEO and CSO

March 18, 2023 | finance.yahoo.com

Avivagen First Quarter 2023 Earnings: CA$0.015 loss per share (vs CA$0.027 loss in 1Q 2022)

February 21, 2023 | msn.com

Avivagen reports FY results

February 21, 2023 | finance.yahoo.com

Avivagen Reports Fiscal Year 2022 Financial Results and Strategic Initiatives to Accelerate Growth

See More Headlines

Receive VIV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Avivagen and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today: 4/19/2024
Next Earnings (Estimated): 4/25/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: CVE
Sector: Medical
Industry: Drug Manufacturers - Specialty & Generic
Sub-Industry: N/A
Current Symbol: CVE:VIV
CUSIP: N/A
CIK: N/A
Web: www.avivagen.com
Phone: 613-949-8164
Fax: N/A
Employees: 13
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): C($0.06)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: C$-4,640,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: -193.44%

Debt

Debt-to-Equity Ratio: 2,402.32
Current Ratio: 0.03
Quick Ratio: 0.30

Sales & Book Value

Annual Sales: C$403,780.00
Price / Sales: 0.96
Cash Flow: C$0.00 per share
Price / Cash Flow: 12.14
Book Value: C($0.10) per share
Price / Book: -0.05

Miscellaneous

Outstanding Shares: 77,690,000
Free Float: N/A
Market Cap: C$388,450.00
Optionable: Not Optionable
Beta: 1.21

Metaverse Stocks And Why You Can't Ignore Them

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

Mr. G. F. Kym Anthony (Age 68)
CEO & Vice Chairman
Comp: $361.06k
Dr. Graham Burton Ph.D.
Co-Founder, Chief Scientific Officer & Director
Mr. Ira Levy
Interim Chief Financial Officer
Dr. James Nickerson Ph.D.
President and Executive VP of Business Development & Product Innovation
Mr. Drew Basek
Director of Investor Relations
Ms. Tracy Gillett BVSC
Director of Companion Animal & Marketing Manager

Key Competitors

View All Competitors

VIV Stock Analysis - Frequently Asked Questions

How have VIV shares performed in 2024?: Avivagen's stock was trading at C$0.01 at the beginning of the year. Since then, VIV stock has increased by 0.0% and is now trading at C$0.01.
View the best growth stocks for 2024 here.
When is Avivagen's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, April 25th 2024.
View our VIV earnings forecast.
What other stocks do shareholders of Avivagen own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Avivagen investors own include Astrotech (ASTC), Arcturus Therapeutics (ARCT), Aptose Biosciences (APTO), Appili Therapeutics (APLIF), Argan (AGX), Applied Genetic Technologies (AGTC), AES (AES) and AbbVie (ABBV).
How do I buy shares of Avivagen?: Shares of VIV stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (CVE:VIV) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial